INOVIO PHARMACEUTICALS, INC. Effective Income Tax Rate Reconciliation, Other Adjustments, Amount
INOVIO PHARMACEUTICALS, INC. (INO) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Amount of $118.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationOtherAdjustments · last filed 2026-03-12
- INOVIO PHARMACEUTICALS, INC. effective income tax rate reconciliation, other adjustments, amount for fiscal 2025 was $118.00K, a 38.86% decline from fiscal 2024.
- INOVIO PHARMACEUTICALS, INC. effective income tax rate reconciliation, other adjustments, amount for fiscal 2024 was $193.00K, a 52.23% decline from fiscal 2023.
- INOVIO PHARMACEUTICALS, INC. effective income tax rate reconciliation, other adjustments, amount for fiscal 2023 was $404.00K, a 87.55% decline from fiscal 2022.
- INOVIO PHARMACEUTICALS, INC. effective income tax rate reconciliation, other adjustments, amount for fiscal 2022 was $3.25M.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 12 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 12 month as first filed |
|---|---|---|
| 2025-12-31 | $118.00K 10-K · filed 2026-03-12 | |
| 2024-12-31 | $193.00K 10-K · filed 2026-03-12 | $1.21M 10-K · filed 2025-03-18 |
| 2023-12-31 | $404.00K 10-K · filed 2025-03-18 | |
| 2022-12-31 | $3.25M 10-K · filed 2024-03-06 | |
| 2021-12-31 | -$819.00K 10-K · filed 2024-03-06 | |
| 2020-12-31 | $920.00K 10-K · filed 2023-03-01 | |
| 2019-12-31 | $831.00K 10-K · filed 2022-03-01 | |
| 2018-12-31 | -$102.00K 10-K · filed 2021-03-01 | |
| 2017-12-31 | $2.09M 10-K · filed 2020-03-12 | |
| 2016-12-31 | $501.00K 10-K · filed 2019-03-12 | |
| 2015-12-31 | $396.00K 10-K · filed 2018-03-14 | |
| 2014-12-31 | -$8.00K 10-K · filed 2017-03-15 | $332.00K 10-K · filed 2015-03-16 |
| 2013-12-31 | -$12.00K 10-K · filed 2016-03-14 | -$479.00K 10-K · filed 2014-03-17 |
| 2012-12-31 | $42.00K 10-K · filed 2015-03-16 | $495.00K 10-K · filed 2013-03-18 |
| 2011-12-31 | $1.27M 10-K · filed 2014-03-17 | |
| 2010-12-31 | $33.00K 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |